MELODIKIR Trademark

Trademark Overview

On Wednesday, March 8, 2017, a trademark application was filed for MELODIKIR with the United States Patent and Trademark Office. The USPTO has given the MELODIKIR trademark a serial number of 87362869. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 28, 2020. This trademark is owned by AbbVie Inc.. The MELODIKIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
melodikir

General Information

Serial Number87362869
Word MarkMELODIKIR
Filing DateWednesday, March 8, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 28, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, September 28, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, March 2, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2020EXTENSION 5 GRANTED
Wednesday, February 5, 2020EXTENSION 5 FILED
Monday, February 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 5, 2020TEAS EXTENSION RECEIVED
Friday, August 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2019EXTENSION 4 GRANTED
Wednesday, August 21, 2019EXTENSION 4 FILED
Wednesday, August 21, 2019TEAS EXTENSION RECEIVED
Saturday, February 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 21, 2019EXTENSION 3 GRANTED
Thursday, February 21, 2019EXTENSION 3 FILED
Thursday, February 21, 2019TEAS EXTENSION RECEIVED
Thursday, August 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 21, 2018EXTENSION 2 GRANTED
Tuesday, August 21, 2018EXTENSION 2 FILED
Tuesday, August 21, 2018TEAS EXTENSION RECEIVED
Wednesday, February 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 19, 2018EXTENSION 1 GRANTED
Monday, February 19, 2018EXTENSION 1 FILED
Monday, February 19, 2018TEAS EXTENSION RECEIVED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, April 30, 2017ASSIGNED TO EXAMINER
Monday, March 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 11, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

melodikir hormonal dermatological gastrointestinal neurological ophthalmic respiratory psychiatric immune disorders vaccines